Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.
Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, Narayan KM, Nwachuku C, O'Connor PJ, Zhang P; ACCORD Study Group.
Am J Cardiol. 2007 Jun 18;99(12A):90i-102i. Epub 2007 Apr 13.PMID: 17599429 [PubMed - indexed for MEDLINE]Related articles